Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACvAD: ACEI/CCB vs ACEI/DIU in Chinese Hypertensive Patients
NCT03682692Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jun 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of benazepril, amlodipine and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Reduction of 24-hour ambulatory systolic blood pressure at 6 months. Started Jun 2018; status: completed.
02
Drugs
benazeprilamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03682692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03682692.